JP2011050347A - alpha-LINOLENIC ACID-ENRICHED EGG AND USE THEREOF - Google Patents
alpha-LINOLENIC ACID-ENRICHED EGG AND USE THEREOF Download PDFInfo
- Publication number
- JP2011050347A JP2011050347A JP2009203919A JP2009203919A JP2011050347A JP 2011050347 A JP2011050347 A JP 2011050347A JP 2009203919 A JP2009203919 A JP 2009203919A JP 2009203919 A JP2009203919 A JP 2009203919A JP 2011050347 A JP2011050347 A JP 2011050347A
- Authority
- JP
- Japan
- Prior art keywords
- wood vinegar
- linolenic acid
- enriched
- solution
- eggs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013601 eggs Nutrition 0.000 claims abstract description 70
- 239000000052 vinegar Substances 0.000 claims abstract description 55
- 235000021419 vinegar Nutrition 0.000 claims abstract description 55
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 44
- 239000002023 wood Substances 0.000 claims abstract description 42
- 230000000694 effects Effects 0.000 claims abstract description 23
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 22
- 229960004488 linolenic acid Drugs 0.000 claims abstract description 22
- 210000004369 blood Anatomy 0.000 claims abstract description 14
- 239000008280 blood Substances 0.000 claims abstract description 14
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- 244000000231 Sesamum indicum Species 0.000 claims description 4
- 230000000172 allergic effect Effects 0.000 claims description 3
- 208000010668 atopic eczema Diseases 0.000 claims description 3
- 238000012360 testing method Methods 0.000 abstract description 12
- 230000006870 function Effects 0.000 abstract description 8
- 241001465754 Metazoa Species 0.000 abstract description 6
- 206010010774 Constipation Diseases 0.000 abstract description 5
- 208000008589 Obesity Diseases 0.000 abstract description 5
- 230000003266 anti-allergic effect Effects 0.000 abstract description 5
- 210000000936 intestine Anatomy 0.000 abstract description 5
- 235000020824 obesity Nutrition 0.000 abstract description 5
- 230000035755 proliferation Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 235000004348 Perilla frutescens Nutrition 0.000 abstract 1
- 229940039696 lactobacillus Drugs 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 22
- 239000000243 solution Substances 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 241000894006 Bacteria Species 0.000 description 11
- 239000004310 lactic acid Substances 0.000 description 11
- 235000014655 lactic acid Nutrition 0.000 description 11
- 241000207961 Sesamum Species 0.000 description 10
- 235000013330 chicken meat Nutrition 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 238000012216 screening Methods 0.000 description 6
- 238000000197 pyrolysis Methods 0.000 description 5
- 239000013566 allergen Substances 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003921 oil Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 241000218645 Cedrus Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000002969 egg yolk Anatomy 0.000 description 3
- 210000003617 erythrocyte membrane Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000017448 oviposition Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 241000208140 Acer Species 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 235000013605 boiled eggs Nutrition 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 240000005109 Cryptomeria japonica Species 0.000 description 1
- 241000218691 Cupressaceae Species 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 102000058061 Glucose Transporter Type 4 Human genes 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000009134 Myrica cerifera Nutrition 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 235000010678 Paulownia tomentosa Nutrition 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108091006300 SLC2A4 Proteins 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- 244000061457 Solanum nigrum Species 0.000 description 1
- 241000611866 Tyrophagus putrescentiae Species 0.000 description 1
- 241000190021 Zelkova Species 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 238000004159 blood analysis Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000011121 hardwood Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 235000021027 japanese diet Nutrition 0.000 description 1
- VNYSSYRCGWBHLG-AMOLWHMGSA-M leukotriene B4(1-) Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC([O-])=O VNYSSYRCGWBHLG-AMOLWHMGSA-M 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
Description
本発明は、α−リノレン酸の含有量が高められているα−リノレン酸強化卵及びその用途に関する。 The present invention relates to an α-linolenic acid-enriched egg having a high α-linolenic acid content and use thereof.
近年、日本国内ではスギ花粉症あるいは糖尿病に罹患する人の割合が増加している。数多くの研究や調査結果から、これらの疾病とα−リノレン酸(以下、単に「LNA」と表わすことがある。)摂取との関連性が報告され、LNA摂取の重要性が明らかになっている。一方で、現代の日本人はリノール酸を初めとするn−6系脂肪酸の過剰摂取が指摘され、「日本人の食事摂取基準(2005年版)」にはLNAに代表されるn−3系脂肪酸やn−6系脂肪酸の摂取目標量が設定され、摂取脂肪酸の適正化をはかるためには食餌中のn−3系脂肪酸の摂取量と摂取比を増加させる必要があるとされている。 In recent years, the percentage of people suffering from Japanese cedar pollinosis or diabetes has increased in Japan. Numerous studies and survey results have reported the relationship between these diseases and the intake of α-linolenic acid (hereinafter sometimes simply referred to as “LNA”), and the importance of LNA intake has been clarified. . On the other hand, modern Japanese people have pointed out excessive intake of n-6 fatty acids such as linoleic acid, and “Japanese dietary intake standards (2005 edition)” are n-3 fatty acids represented by LNA. In addition, a target intake amount of n-6 fatty acids is set, and it is said that in order to optimize the intake fatty acids, it is necessary to increase the intake amount and intake ratio of n-3 fatty acids in the diet.
しかし、LNAが多く含まれている食品は少なく、また、食用油の形態で摂取するには酸化されやすいため、家庭での保存・利用が難しいという一面がある。 However, there are few foods that contain a lot of LNA, and since they are easily oxidized when ingested in the form of edible oil, there is one aspect that it is difficult to store and use at home.
ここで、鶏卵は栄養価が高く、日本人の食生活に浸透しており、LNAを強化した鶏卵を供給源として利用することにより、LNAを日常的かつ継続的に摂取することが可能である。 Here, chicken eggs are highly nutritious and have penetrated the Japanese diet, and it is possible to ingest LNA daily and continuously by using chicken eggs enriched with LNA as a source. .
そして、LNAや、LNAの含有量が高められているLNA強化卵及びLNA強化卵によって発揮される効果に関しては、以下のように、従来から種々の提案、報告がされている。 And regarding the effects exhibited by LNA, LNA-enriched eggs in which the content of LNA is increased, and LNA-enriched eggs, various proposals and reports have been made as follows.
特許文献1には、エゴマ種子を給餌することにより、LNAの含有量が高められている鳥獣肉類・乳・卵等の動物性食品が得られること、そして、このLNAの含有量が高められている鶏卵などにはアレルギー反応の抑制効果があることが記載されている。
In
非特許文献1には、産卵鶏にエゴマ種子を給餌したところ、卵黄中の脂肪酸組成のn−6/n−3比が有意に低下したことが記載されている。
非特許文献2には、えごま種子が混合されている飼料を経口摂取させることにより、鶏肉、鶏卵の脂肪酸組成におけるリノール酸が低下し、LNAが有意に増加することが記載されている。 Non-Patent Document 2 describes that linoleic acid in the fatty acid composition of chicken meat and eggs decreases and LNA significantly increases by ingesting a feed mixed with sesame seeds.
非特許文献3には、炎症・アレルギー反応に対して増悪的に働くロイコトリエンB4のレベルが、前駆体であるアラキドン酸の減少を反映して低n−6/n−3区で25%減少することが記載されている。 Non-patent document 3 shows that the level of leukotriene B4, which acts exacerbating inflammation and allergic reactions, is reduced by 25% in the low n-6 / n-3 section, reflecting the decrease in the precursor arachidonic acid. It is described.
非特許文献4には、LNAの血糖値降下作用に関する研究が報告されている。 Non-patent document 4 reports a study on the blood glucose level lowering effect of LNA.
このように、LNAには血液粘稠度改善作用、抗動脈硬化作用、肥満や便秘改善効果、更には抗アレルギー効果があることが従来から報告されている。 Thus, it has been reported that LNA has a blood consistency improving effect, an anti-arteriosclerotic effect, an obesity and constipation improving effect, and an antiallergic effect.
そして、しそ科の一年草で含有している脂肪酸の60%がLNAであるエゴマは、これを飼料に含有させることによって、LNAが有する前述した機能性を鶏卵などに移行させ、酸化しやすいというLNAの弱点を補い、日常的に摂取可能にする提案が従来から行われている。 In addition, 60% of the fatty acid contained in the annual grass of Lamiaceae is LNA. By including this in the feed, the above-mentioned functionality of LNA is transferred to chicken eggs, etc., and is easily oxidized. In the past, proposals have been made to compensate for the weaknesses of LNA and to enable daily intake.
一方、木を乾留して得られた粗木酢液から有害物質を分離して精製した木酢精製液を動物に投与すると、動物の腸内に存在する乳酸菌の増殖が促進されることから(特許文献2)、これを飼料に混合して採卵鶏などに経口摂取させ、採卵鶏などの健康を維持・増進することが行われている。 On the other hand, when a purified vinegar solution obtained by separating and purifying harmful substances from the crude vinegar solution obtained by dry distillation of wood is administered to animals, the growth of lactic acid bacteria present in the intestines of the animals is promoted (patent document) 2) This is mixed with feed and taken orally by egg-laying hens to maintain and improve the health of egg-laying hens.
本発明は、血液粘稠度改善作用、抗動脈硬化作用、肥満や便秘改善効果、抗アレルギー効果を発揮させるα−リノレン酸の機能と、動物の腸内に存在する乳酸菌の増殖を促進させる木酢精製液の機能とが相乗的に発揮させられていることをヒト介入試験により確認できるα−リノレン酸強化卵及びその用途を提案することを目的にしている。 The present invention relates to a function of α-linolenic acid that exerts blood consistency improving action, anti-arteriosclerotic action, obesity and constipation improving effect, and anti-allergic effect, and wood vinegar that promotes the growth of lactic acid bacteria present in the intestines of animals. The object is to propose an α-linolenic acid-enriched egg that can be confirmed by a human intervention test that the function of the purified solution is synergistically exhibited and its use.
前記目的を達成するための本願発明は、以下の通りのものである。 The present invention for achieving the above object is as follows.
請求項1記載の発明は、
産卵鶏用飼料に対して、
広葉樹の樹皮を含む木片を200〜380℃で乾留して得られた粗木酢液を3ヶ月以上放置し、上層の軽質油、中間層の木酢液、下層の有害なタール分の三層に分離させた後、中間層の木酢液を分離し、これから3−4ベンツピレンを分離して精製した木酢精製液を0.5〜1.5重量%、
エゴマの種子を2.0〜3.0重量%
含有させてなる産卵鶏用飼料を、
少なくとも5週間以上にわたって経口摂取した産卵鶏が産生したα−リノレン酸強化卵である。
The invention described in
For feed for laying hens,
The crude wood vinegar obtained by dry-distilling wood chips containing broad-leaved bark at 200-380 ° C is allowed to stand for more than 3 months and separated into three layers of light oil in the upper layer, wood vinegar in the middle layer, and harmful tar in the lower layer. After the middle layer of wood vinegar was separated, 0.5 to 1.5% by weight of the wood vinegar purified solution purified by separating 3-4 benzpyrene from this,
Sesame seeds 2.0-3.0% by weight
A feed for laying hens that contains
It is an α-linolenic acid-enriched egg produced by a laying hen that has been orally ingested for at least 5 weeks.
請求項2記載の発明は、
請求項1記載のα−リノレン酸強化卵を少なくとも6カ月以上にわたって一日2個以上経口摂取することにより、人の血糖値低減作用を発揮させる請求項1記載のα−リノレン酸強化卵の用途である。
The invention according to claim 2
The use of an α-linolenic acid-enriched egg according to
請求項3記載の発明は、
請求項1記載のα−リノレン酸強化卵を少なくとも6カ月以上にわたって一日2個以上経口摂取することにより、アレルギー体質改善効果を発揮させる請求項1記載のα−リノレン酸強化卵の用途である。
The invention described in claim 3
The use of the α-linolenic acid-enriched egg according to
本発明によれば、血液粘稠度改善作用、抗動脈硬化作用、肥満や便秘改善効果、抗アレルギー効果を発揮させるα−リノレン酸の機能と、動物の腸内に存在する乳酸菌の増殖を促進させる木酢精製液の機能とが相乗的に発揮させられていることをヒト介入試験により確認できるα−リノレン酸強化卵及びその用途を提供することができる According to the present invention, the function of α-linolenic acid that exerts blood consistency improving action, anti-arteriosclerotic action, obesity and constipation improving effect, and anti-allergic effect, and the growth of lactic acid bacteria existing in the intestines of animals are promoted. Α-linolenic acid-enriched eggs that can be confirmed by a human intervention test that the functions of the purified vinegar to be synergistically exhibited and the use thereof can be provided
(産卵鶏用飼料の調製)
市販されている産卵鶏用飼料に対して、木を乾留して得られた粗木酢液から有害物質を分離して精製した木酢精製液を0.5〜1.5重量%と、エゴマの種子を2.0〜3.0重量%添加混合して産卵鶏用飼料を調製する。
(Preparation of feed for laying hens)
Sesame seeds, 0.5-1.5% by weight of a purified vinegar solution obtained by separating and purifying toxic substances from a crude vinegar solution obtained by dry distillation of wood against commercially available feed for laying hens Is mixed with 2.0 to 3.0% by weight to prepare a feed for laying hens.
ここで、エゴマは島根県産のもの(奥出雲町産、または川本町産)を用いた。 Here, egoma was produced in Shimane Prefecture (Okuzumo-cho or Kawamoto-cho).
前記の木酢精製液は次のようにして準備した。 The purified vinegar solution was prepared as follows.
広葉樹の樹皮を含む木片を200〜380℃で乾留して得られた粗木酢液を3ヶ月以上放置し、上層の軽質油、中間層の木酢液、下層の有害なタール分の三層に分離させる。その後、中間層の木酢液を分離し、これから3−4ベンツピレンを分離して精製した。 The crude wood vinegar obtained by dry-distilling wood chips containing broad-leaved bark at 200-380 ° C is allowed to stand for more than 3 months and separated into three layers of light oil in the upper layer, wood vinegar in the middle layer, and harmful tar in the lower layer. Let Thereafter, the wood vinegar solution of the intermediate layer was separated, and 3-4 benzpyrene was separated therefrom and purified.
木としては、発明の効果の観点から、広葉樹の樹皮を含む木片であるのが好ましい。広葉樹は、森林保護、廃物の有効活用という観点から、従来有効な用途が考えられなかったスギ、ヒノキ、カラマツなどの間伐材を用いることもできる。なお、処理熱効率などの観点から、樹皮を細かく砕いたバーグ材が好ましい。また、昔より漢方薬の原料として使用されていたという理由から、カシ、タブ、サクラ、カエデ、シイ、クス、イス、ナラ、キハダ、ヤマモモ、カシワ、ケヤキ、クワ、キリ、ミズキ、ソヤのいずれか一種を含有するものにするとより好ましい。 From the viewpoint of the effects of the invention, the tree is preferably a piece of wood containing a bark of a broad-leaved tree. Deciduous trees such as cedar, cypress, and larch, which have not been considered useful in the past, can also be used for broadleaf trees from the viewpoint of forest protection and effective use of waste. In addition, from the viewpoint of processing heat efficiency and the like, a bark material obtained by finely pulverizing bark is preferable. Also, because it has been used as a raw material for traditional Chinese medicine, it is one of oak, tab, cherry, maple, shii, kusu, chair, oak, kihada, bayberry, oak, zelkova, mulberry, kiri, mizuki, soya It is more preferable to contain one kind.
広葉樹の樹皮を含む木片を200〜380℃で乾留する際にはガスが発生するが、そのガスを集めて冷却すると、粗木酢液を得ることができる。 When a piece of wood containing hardwood bark is dry-distilled at 200 to 380 ° C., gas is generated. When the gas is collected and cooled, a crude wood vinegar can be obtained.
この粗木酢液は3ヶ月以上放置すると、前記のように上層の軽質油、中間層の木酢液、下層の有害なタール分の三層に分離するため、この三層から中間層の木酢液を分離する。 If this crude wood vinegar is left for more than 3 months, it is separated into three layers of light oil in the upper layer, wood vinegar in the middle layer and harmful tar in the lower layer as described above. To separate.
分離された木酢液は、有害物質を含むため、蒸留して精製する。蒸留方法としては、120℃以下で反復蒸留する方法を挙げることができるが、これに限定されない。木酢液から有害物質である3−4ベンツピレンを除去して木酢精製液とした。 Since the separated wood vinegar liquid contains harmful substances, it is purified by distillation. Examples of the distillation method include a method of repeated distillation at 120 ° C. or lower, but are not limited thereto. 3-4 Benzpyrene, which is a harmful substance, was removed from the wood vinegar solution to obtain a wood vinegar purified solution.
このようにして調製した木酢精製液の性質の一例を表1に示す。
前記において、市販されている産卵鶏用飼料に対して添加、混合する木酢精製液を0.5〜1.5重量%、エゴマの種子を2.0〜3.0重量%としたのは、このように調製された産卵鶏用飼料を経口摂取する産卵鶏の腸内に存在する乳酸菌を増殖させて産卵鶏の健康を維持・増進させるという前述した木酢精製液の機能と、鶏卵に移行したα−リノレン酸が有する血液粘稠度改善作用、抗動脈硬化作用、肥満や便秘改善効果、抗アレルギー効果とを相乗的に発揮させる観点からである。なお、配合割合がこれらより少ない場合、目的とした機能・効果の発揮が十分ではなく、一方で、費用・効果の観点から、配合割合は前記の上限で十分と認められた。 In the above, 0.5 to 1.5% by weight of purified vinegar to be added to and mixed with commercially available feed for laying hens, and 2.0 to 3.0% by weight of sesame seeds, The function of the above-described wood vinegar refinement solution that allows the lactic acid bacteria present in the intestine of the laying hen to be ingested orally to maintain and enhance the health of the laying hen, and transferred to the hen's egg. This is from the viewpoint of synergistically exhibiting the blood consistency improving action, anti-arteriosclerotic action, obesity and constipation improving effect and anti-allergic effect of α-linolenic acid. When the blending ratio is less than these, the intended function / effect is not sufficiently exhibited. On the other hand, the blending ratio is recognized to be sufficient from the viewpoint of cost and effect.
(鶏の飼養及び採卵)
前記のように調製した木酢精製液及びエゴマ種子含有産卵鶏用飼料を通常の要領で産卵鶏に給与しつつ、産卵鶏が産生する鶏卵の脂肪酸分析を行った。
(Feeding and collecting eggs)
The fatty acid analysis of the egg produced by the laying hen was conducted while feeding the purified vinegar and the feed for the sesame seed-containing laying hen as described above to the laying hen.
給与開始から5週間経過したところで卵黄中のLNA含量が安定に達し、LNA含量は1個あたり170〜240mgになった(以下、木酢精製液及びエゴマ種子含有産卵鶏用飼料を5週間にわたって給与した産卵鶏が産生した鶏卵(LNA含量:170〜240mg/個)を「LNA強化卵」という。)。 After 5 weeks from the start of feeding, the LNA content in the yolk reached a stable level, and the LNA content was 170-240 mg per piece (hereinafter, the feed for egg laying hens containing the purified vinegar and sesame seeds was fed for 5 weeks. Eggs produced by laying hens (LNA content: 170-240 mg / piece) are referred to as “LNA-enriched eggs”).
比較対象として、前記と同様に木酢精製液を0.5〜1.5重量%添加・混合したが、エゴマ種子は添加・混合していない、市販の産卵鶏用飼料を給与した産卵鶏が産生する鶏卵についても脂肪酸分析を行ったところ、卵黄中のLNA含量は給与開始から5週間経過したところでも約30mg/個であった(以下、木酢精製液を0.5〜1.5重量%添加・混合しているが、エゴマ種子は添加・混合していない、市販の産卵鶏用飼料を5週間にわたって給与した産卵鶏が産生した鶏卵を「普通卵」という。)。 As a comparison object, 0.5 to 1.5% by weight of purified vinegar was added and mixed in the same manner as described above, but no sesame seeds were added or mixed. The fatty acid analysis was also performed on the eggs to be processed, and the LNA content in the yolk was about 30 mg / piece even after 5 weeks from the start of feeding (hereinafter, 0.5 to 1.5% by weight of a purified vinegar solution was added) -Eggs produced by laying hens that have been fed commercially available feed for laying hens with mixed but not added sesame seeds are referred to as "normal eggs").
(ヒトによる経口摂取方法、呈味試験)
LNA強化卵について、生食の場合、これを用いて調理したゆで卵、温泉卵についてLNA含量を比較したところ、いずれも残存率が高く、これらの食べ方が望ましいと考えられた。
(Method of oral intake by humans, taste test)
As for LNA-enriched eggs, in the case of raw food, when the LNA content of boiled eggs cooked using this and hot spring eggs were compared, the residual ratio was high, and it was considered that these eating methods were desirable.
また、普通卵、LNA強化卵をそれぞれゆで卵とし、食味について比較検討したところ、普通卵、LNA強化卵の間に食味の相違は認められなかった。 In addition, when normal eggs and LNA-enriched eggs were boiled eggs, and the taste was compared, no difference in taste was found between the normal eggs and LNA-enriched eggs.
(ヒト介入試験)
事前の生活習慣調査と血液検査の結果から介入試験参加者を抽出し、初回検診で判明したアレルゲン陽性の参加者を、普通卵を摂取する群(普通卵摂取群:51名:男性33名・女性18名)と、LNA強化卵を摂取する群(LNA強化卵摂取群:51名:男性33名・女性18名)とに分けて、参加者に、それぞれ、普通卵、LNA強化卵を6カ月にわたり1日あたり2個ずつ摂取してもらい、6カ月にわたって以下のスケジュールでヒト介入試験を行った。
(Human intervention study)
Intervention trial participants were extracted from the results of prior lifestyle surveys and blood tests, and allergen positive participants found by the initial screening were taken into the group that ingested normal eggs (normal egg intake group: 51 people: 33 men) 18 women) and LNA-enriched eggs (LNA-enriched egg intake group: 51 people: 33 men / 18 women). Each participant received 6 normal eggs and LNA-enriched eggs. The human intervention study was conducted on the following schedule over 6 months.
(スケジュール)
初回検診 説明会。採血。介入試験参加者のスクリーニング
初回検診から約2カ月後
介入試験参加者への説明会
介入試験開始
介入試験開始から3カ月経過後 検診及び採血
介入試験開始から6カ月経過後 検診及び採血
(調査項目)
検診:問診、身長、体重、体脂肪率、血圧、腹囲、視力
血液分析:
生化学検査
総コレストロール、LDL−コレストロール、HDL−コレストロール、トリグリセリド、血糖、グリコヘモグロビンA1c、尿素窒素、クレアチニン、アルブミン、GOT、GPT、γGTP
アレルゲン検査
スギ花粉、コヒョウダニ、ハウスダスト、卵白、エビ
脂肪酸分析
血漿と赤血球膜の脂肪酸含量と組成
血清骨代謝マーカー
卵の摂取状況:個数と食べ方
(ヒト介入試験結果)
摂取3カ月後、6カ月後にはLNA強化卵摂取群は、普通卵摂取群に比べて赤血球膜DHA含有率が増加した。
(Schedule)
First medical examination briefing session. Blood collection. Screening of intervention trial participants About 2 months after initial screening
Briefing session for intervention participants
Intervention test started 3 months after the start of the intervention test Screening and blood sampling 6 months after the start of the intervention test Screening and blood sampling (survey items)
Screening: Interview, height, weight, body fat percentage, blood pressure, waist circumference, visual acuity Blood analysis:
Biochemical test Total cholesterol, LDL-cholestrol, HDL-cholestrol, triglyceride, blood glucose, glycohemoglobin A1c, urea nitrogen, creatinine, albumin, GOT, GPT, γGTP
Allergen test Cedar pollen, mushroom mite, house dust, egg white, shrimp Fatty acid analysis Fatty acid content and composition of plasma and erythrocyte membrane Serum bone metabolism marker Egg consumption: number and how to eat (results of human intervention study)
At 3 months and 6 months after the intake, the LNA-enriched egg intake group increased the erythrocyte membrane DHA content compared to the normal egg intake group.
摂取6カ月後にはLNA強化卵摂取群は、普通卵摂取群に比べて血糖が有意に低下することが示唆された。 It was suggested that blood glucose was significantly reduced in the LNA-enriched egg intake group 6 months after the intake compared to the normal egg intake group.
摂取6カ月後にはLNA強化卵摂取群は、普通卵摂取群に比べてアレルゲン抗体価のクラスダウンしない人数が少ないことから、LNA強化卵によるアレルギー体質改善効果が推察された。 Six months after the ingestion, the LNA-enriched egg ingestion group had fewer allergen antibody titers than the normal egg ingestion group, suggesting that the LNA-enriched egg improved the allergic constitution.
(木酢精製液の作成)
新鮮なカシ、シイ、タブ、サクラ及びカエデの樹皮を含む乾燥木片25トンを原料として乾留炉に投入し、350℃で、168時間乾留を行った。
(Preparation of purified vinegar)
25 tons of dry wood pieces containing fresh oak, shii, tub, cherry and maple bark were used as raw materials and placed in a dry distillation furnace and subjected to dry distillation at 350 ° C. for 168 hours.
乾留の際に発生したガスを収集し、自然冷却により粗木酢液を得た。 The gas generated during dry distillation was collected, and a crude wood vinegar solution was obtained by natural cooling.
得られた粗木酢液を分離槽に3ヶ月以上静置し、上層の軽質油、中間層の木酢液、下層の有害なタール分の三層に分離した分離粗木酢液を得た。 The obtained crude wood vinegar was allowed to stand in a separation tank for 3 months or longer to obtain a separated crude wood vinegar separated into three layers of an upper layer of light oil, an intermediate layer of wood vinegar, and a lower layer of harmful tar.
分離粗木酢液から中間層の木酢液を分離し、木酢液を得た。 An intermediate layer of wood vinegar was separated from the separated crude wood vinegar to obtain a wood vinegar.
この木酢液から有害物質が検出されなくなるまで120℃以下で反復蒸留して精製し、約1トンの木酢精製液を得た。 The vinegar solution was purified by repeated distillation at 120 ° C. or lower until no harmful substances were detected, and about 1 ton of vinegar solution was obtained.
この木酢精製液は、無色透明の液体で、特異な焦臭と酸味があり、18℃におけるpHをデジタルpHメーターで測定したところ、3.7であった。また、5mlの木酢精製液に硫酸1mlを加えて加熱したところ、酢酸のにおいを発した。さらに、5mlの木酢精製液に水酸化ナトリウム試液を加えて中和し、塩化第二鉄試液を滴加したところ、液は赤褐色を呈し、煮沸したところ、赤褐色の沈殿を生じた。 This purified vinegar solution was a colorless and transparent liquid, had a unique burning odor and acidity, and its pH at 18 ° C. measured by a digital pH meter was 3.7. In addition, when 1 ml of sulfuric acid was added to 5 ml of purified vinegar and heated, the smell of acetic acid was emitted. Furthermore, when sodium hydroxide test solution was added to 5 ml of purified wood vinegar for neutralization and ferric chloride test solution was added dropwise, the solution became reddish brown and boiled, resulting in a reddish brown precipitate.
木酢精製液の正常細菌叢(乳酸産生菌)に対する影響を明らかにするため、E.faeciumを107個接種した培地を13個用意し、これを9個と4個の2つのグループに分けた。9個の培地のそれぞれに、木酢精製液:0重量%、0.25重量%、0.5重量%、1重量%、2重量%、酢酸:0.25重量%、0.5重量%、1重量%、2重量%を加え、その後、それぞれのpHを7にして乳酸産生菌の増殖を調べた。また、4個の培地のそれぞれに、酢酸:0.25重量%、0.5重量%、1重量%、2重量%を加え、pHを調整せずに乳酸産生菌の増殖を調べた。その結果を図1に示す。
In order to clarify the effect of purified vinegar on normal bacterial flora (lactic acid producing bacteria), was prepared 13 pieces of
木酢精製液の添加量が増加するにつれて、乳酸産生菌の増殖が促進されたが、酢酸は乳酸産生菌の増殖に何ら影響を与えず、むしろ増殖抑制効果を示した。 As the amount of the purified vinegar solution increased, the growth of lactic acid-producing bacteria was promoted, but acetic acid had no effect on the growth of lactic acid-producing bacteria, but rather showed a growth inhibitory effect.
これより、木酢精製液は、乳酸産生菌に対して増殖促進効果を示すことを確認できた。 From this, it was confirmed that the pyroligneous acid purified solution showed a growth promoting effect against lactic acid-producing bacteria.
(産卵鶏用飼料の調製)
市販されている産卵鶏用飼料100kgに対して、前記のように準備した木酢精製液を0.1kgと、島根県川本町産エゴマの種子2.5kgを添加混合して産卵鶏用飼料を調製した。
(Preparation of feed for laying hens)
To 100 kg of laying hen feed commercially available, 0.1 kg of the purified vinegar solution prepared as described above and 2.5 kg of sesame seeds from Kawamoto-cho, Shimane are added and mixed to prepare feed for laying hen did.
(鶏の飼養及び採卵)
前記のように調製した木酢精製液及びエゴマ種子含有産卵鶏用飼料を通常の要領で産卵鶏に5週間にわたって給与し、摂取期間5週間を経過した産卵鶏が産生したLNA強化卵と、比較対象のために、前記と同様に、市販されている産卵鶏用飼料100kgに対して木酢精製液を0.1kg添加・混合したが、エゴマ種子を添加・混合しなかった産卵鶏用飼料を5週間にわたって摂取し続けた産卵鶏が産生した普通卵とを前記のヒト介入試験に供し、前記のスケジュール、調査項目でのヒト介入試験を行った。
(Feeding and collecting eggs)
Compared with LNA-enriched eggs produced by laying hens that had been supplied with the purified vinegar and sesame seed-containing laying hen feed as described above for 5 weeks, and that had been ingested for 5 weeks. Therefore, in the same manner as described above, 100 kg of commercially available feed for laying hens was added and mixed with 0.1 kg of pyroligneous acid but no sesame seeds were added or mixed for 5 weeks. The normal eggs produced by the laying hens that had been ingested over a long period of time were subjected to the human intervention test, and the human intervention test was conducted according to the schedule and survey items.
その結果は以下の表2通りであった。
ヒト介入試験の結果、スギ花粉陽性者における最高レベルの群は、陰性群に比べて血漿中のLNA、EPA、DHA量が有意に低い値を示すことを確認できた。 As a result of the human intervention test, it was confirmed that the highest level group in the cedar pollen positive group showed significantly lower values of LNA, EPA, and DHA in plasma than the negative group.
また、摂取6カ月後には普通卵摂取群、LNA強化卵摂取群ともに赤血球膜DHA含有率は増加するが、普通卵摂取群に比べてLNA強化卵摂取群ではその増加量が有意に高い値を示した。 In addition, the erythrocyte membrane DHA content increases in the normal egg intake group and the LNA-enriched egg intake group 6 months after the intake, but the increase in the LNA-enriched egg intake group is significantly higher than that in the normal egg intake group. Indicated.
更に、摂取6カ月後には普通卵摂取群、LNA強化卵摂取群ともに血糖値が増加するが、その増加量は、LNA強化卵摂取群では、普通卵摂取群に比べて有意に低い値が示された。このことから、LNA酸強化卵を少なくとも6カ月以上にわたって一日2個以上経口摂取することにより血糖値を低減させる作用が発揮される可能性が示唆された。 Furthermore, after 6 months of intake, blood glucose levels increased in both the normal egg intake group and the LNA-enriched egg intake group, but the increase was significantly lower in the LNA-enriched egg intake group than in the normal egg intake group. It was done. From this, it was suggested that the effect of reducing blood glucose level may be exerted by ingesting two or more LNA acid-enriched eggs per day for at least 6 months or more.
また、摂取6カ月後には普通卵摂取群、LNA強化卵摂取群ともにアレルゲン陽性のクラスレベルは低下するが、低下しなかったヒトの割合は、普通卵摂取群の方が、LNA強化卵摂取群に比べて有意に多かった。このことから、LNA強化卵を少なくとも6カ月以上にわたって一日2個以上経口摂取することにより、アレルギー体質改善効果が発揮される可能性が示唆された。 In addition, after 6 months of intake, both the normal egg intake group and the LNA-enriched egg intake group had decreased allergen-positive class levels, but the percentage of humans that did not decrease was that the normal egg intake group was the LNA-enriched egg intake group. There were significantly more than From this, it was suggested that the allergy constitution improving effect may be exhibited by orally ingesting 2 or more LNA-enriched eggs per day for at least 6 months or more.
以上、本発明の好ましい実施形態、実施例を説明したが、本発明はかかる実施形態、実施例に限定されるものではなく、特許請求の範囲の記載から把握される技術的範囲において種々の形態に変更可能である。 The preferred embodiments and examples of the present invention have been described above. However, the present invention is not limited to the embodiments and examples, and various forms are possible within the technical scope grasped from the description of the claims. Can be changed.
Claims (3)
広葉樹の樹皮を含む木片を200〜380℃で乾留して得られた粗木酢液を3ヶ月以上放置し、上層の軽質油、中間層の木酢液、下層の有害なタール分の三層に分離させた後、中間層の木酢液を分離し、これから3−4ベンツピレンを分離して精製した木酢精製液を0.5〜1.5重量%、
エゴマの種子を2.0〜3.0重量%
含有させてなる産卵鶏用飼料を、
少なくとも5週間以上にわたって経口摂取した産卵鶏が産生したα−リノレン酸強化卵。 For feed for laying hens,
The crude wood vinegar obtained by dry-distilling wood chips containing broad-leaved bark at 200-380 ° C is allowed to stand for more than 3 months and separated into three layers of light oil in the upper layer, wood vinegar in the middle layer, and harmful tar in the lower layer. After the middle layer of wood vinegar was separated, 0.5 to 1.5% by weight of the wood vinegar purified solution purified by separating 3-4 benzpyrene from this,
Sesame seeds 2.0-3.0% by weight
A feed for laying hens that contains
Α-linolenic acid-enriched eggs produced by laying hens taken orally for at least 5 weeks or more.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009203919A JP2011050347A (en) | 2009-09-03 | 2009-09-03 | alpha-LINOLENIC ACID-ENRICHED EGG AND USE THEREOF |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009203919A JP2011050347A (en) | 2009-09-03 | 2009-09-03 | alpha-LINOLENIC ACID-ENRICHED EGG AND USE THEREOF |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2011050347A true JP2011050347A (en) | 2011-03-17 |
Family
ID=43940027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009203919A Pending JP2011050347A (en) | 2009-09-03 | 2009-09-03 | alpha-LINOLENIC ACID-ENRICHED EGG AND USE THEREOF |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2011050347A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103518979A (en) * | 2012-07-02 | 2014-01-22 | 马万龙 | Organic livestock and egg feed rich in linolenic acid, and feeding method of feed |
| JP2015003900A (en) * | 2013-05-23 | 2015-01-08 | 宮崎みどり製薬株式会社 | Dermanyssus gallinae control agent |
| JP2017008022A (en) * | 2015-06-17 | 2017-01-12 | ハルビン メディカル ユニバーシティーHarbin Medical University | Methods in the manufacture of drugs for the treatment of allergic rhinitis |
| CN109315348A (en) * | 2017-08-01 | 2019-02-12 | 郭卫民 | A kind of cultural method of spicy hot pig |
| CN109770058A (en) * | 2019-02-22 | 2019-05-21 | 郭卫民 | A kind of fibre plant biological fermentation feed |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002360184A (en) * | 2001-06-06 | 2002-12-17 | Harumi Okuyama | Animal food for improving allergic constitution |
| JP2005318856A (en) * | 2004-05-11 | 2005-11-17 | Miyazaki Midori Seiyaku Kk | Growth promoter for lactic acid bacterium |
-
2009
- 2009-09-03 JP JP2009203919A patent/JP2011050347A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002360184A (en) * | 2001-06-06 | 2002-12-17 | Harumi Okuyama | Animal food for improving allergic constitution |
| JP2005318856A (en) * | 2004-05-11 | 2005-11-17 | Miyazaki Midori Seiyaku Kk | Growth promoter for lactic acid bacterium |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103518979A (en) * | 2012-07-02 | 2014-01-22 | 马万龙 | Organic livestock and egg feed rich in linolenic acid, and feeding method of feed |
| JP2015003900A (en) * | 2013-05-23 | 2015-01-08 | 宮崎みどり製薬株式会社 | Dermanyssus gallinae control agent |
| JP2017008022A (en) * | 2015-06-17 | 2017-01-12 | ハルビン メディカル ユニバーシティーHarbin Medical University | Methods in the manufacture of drugs for the treatment of allergic rhinitis |
| CN109315348A (en) * | 2017-08-01 | 2019-02-12 | 郭卫民 | A kind of cultural method of spicy hot pig |
| CN109315348B (en) * | 2017-08-01 | 2021-03-19 | 郭卫民 | Breeding method of spicy pigs |
| CN109770058A (en) * | 2019-02-22 | 2019-05-21 | 郭卫民 | A kind of fibre plant biological fermentation feed |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shewita et al. | Effect of dietary supplementation of different levels of black seed (Nigella Sativa L.) on growth performance, immunological, hematological and carcass parameters of broiler chicks | |
| El-Sabrout et al. | Current applications and trends in rabbit nutraceuticals | |
| Butnariu et al. | What is sodium glutamate and what effects it has on health | |
| Donma et al. | Beneficial effects of poultry meat consumption on cardiovascular health and the prevention of childhood obesity | |
| TWI627959B (en) | Use of lactobacillus reuteri gmnl-263 for manufacturing composition for increasing expression of ldl-r and cyp7a1 in liver in high-fat diet individual | |
| KR100872457B1 (en) | Production method of functional egg with lowered cholesterol and increased calcium and egg prepared by the above method | |
| Ao et al. | Influence of fermented red ginseng extract on broilers and laying hens | |
| Ahmed et al. | Improving the nutritional quality and shelf life of broiler meat by feeding diets supplemented with fermented pomegranate (Punica granatum L.) by-products | |
| EP1996032A1 (en) | A non marine or non algal sourced omega 3 feed/food supplement and process for stabilizing, enhancing the conversion efficiency, and enrichment of omega 3 fatty acids in livestock/humans and products therefrom | |
| JP2011050347A (en) | alpha-LINOLENIC ACID-ENRICHED EGG AND USE THEREOF | |
| El-Ghousein | Effect of some medicinal plants as feed additives on lactating awassi ewe performance, milk composition, lamb growth and relevant blood items | |
| JP2021104069A (en) | Functional feed | |
| WO2010113886A1 (en) | Agent for promoting weight gain in livestock, feed for promoting weight gain and method for promoting weight gain | |
| Ulsagheer Mohanad et al. | Effect of using natural apple vinegar, garlic powder (Alsin) and black bean seed on the immune system and some of characteristics of the blood broilers Ross 308 | |
| JPS5832867B2 (en) | Eggs containing high concentrations of lysozyme and iodine | |
| JP5156330B2 (en) | Adipose tissue weight reducing agent | |
| Ogbuewu et al. | Enhancement of nutritional and functional qualities of tropical leaf meal as feed ingredients in chickens through the use of fermentation technology | |
| KR100793645B1 (en) | Functional feed additive | |
| Dedousi et al. | Growth Performance, Meat Quality, Welfare and Behavior Indicators of Broilers Fed Diets Supplemented with Yarrowia lipolytica Yeast | |
| JP2013060380A (en) | Composition for improving brain function, having black vinegar-derived ingredient as active ingredient | |
| JP2019024481A (en) | Food composition for increasing muscle mass, muscle mass increasing agent, food composition for preventing muscle atrophy and agent for preventing muscle atrophy | |
| KR102390386B1 (en) | Functional beverage composition for companion animal | |
| Ait Saada et al. | Valorization essay of arthrospiraplatensis in alimentation of broilers | |
| Benali et al. | Effect of using prickly Pear seed cake (Opuntia ficus indica L.) on growth Performance, Digestibility, physiological and histometric parameters in rabbits | |
| Sundu | The apparent metabolizable energy and amino acid digestibilities of copra meal in broiler diets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120515 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130124 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130205 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130225 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130319 |